Preprint
Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study
Abstract
Abstract Background Sputnik-V (Gam-COVID-Vac) is a heterologous, recombinant adenoviral (rAdv) vector-based, COVID-19 vaccine now used in >70 countries. Yet there is a shortage of data on this vaccine’s performance in diverse populations. Here, we performed a prospective cohort study to assess the reactogenicity and immunologic outcomes of Sputnik-V vaccination in a multiethnic cohort from Kazakhstan. Methods COVID-19-free participants (n=82 …
Authors
Yegorov S; Kadyrova I; Negmetzhanov B; Kolesnikova Y; Kolesnichenko S; Korshukov I; Baiken Y; Matkarimov B; Miller MS; Hortelano GH
DOI
10.1101/2022.01.26.22269729
Preprint server
medRxiv